Randomized phase II study of pemetrexed plus carboplatin followed by pemetrexed versus paclitaxel plus carboplatin followed by pemetrexed in advanced nonsquamous, non-small cell lung cancer (LOGIK 0904)

被引：0
|
作者：
Takayama, Koichi
Inoue, Koji
Takeshita, Masafumi
Tashiro, Naoki
Harada, Taishi
Seto, Takashi
Imanaga, Tomotoshi
Fujimoto, Noriko
Nakagaki, Noriaki
Kawasaki, Masayuki
Kishimoto, Junji
Ichinose, Yukito
机构：
[1] Kyushu Univ, Res Inst Dis Chest, Grad Sch Med Sci, Fukuoka 812, Japan
[2] Kitakyushu Municipal Med Ctr, Dept Resp Med, Kitakyushu, Fukuoka, Japan
[3] Fukuoka Univ, Sch Med, Dept Resp Med, Fukuoka 81401, Japan
[4] Kyushu Natl Canc Ctr, Dept Med Oncol, Fukuoka, Japan
[5] Steel Mem Yawata Hosp, Dept Resp Dis, Kitakyushu, Fukuoka, Japan
[6] St Marys Hosp, Dept Resp Dis, Kurume, Fukuoka, Japan
[7] Natl Hosp Org Fukuoka Higashi Med Ctr, Dept Resp Dis, Fukuoka, Japan
[8] Natl Hosp Org Omuta Hosp, Dept Resp Med, Omuta, Japan
[9] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka 812, Japan
[10] Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8111
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Randomized, open-label study of pemetrexed/carboplatin followed by maintenance pemetremexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevaciztimab in patients with advanced non-small cell lung cancer (NSCLC) of nonsquamous histology
    Zinner, R.
    Saxman, S.
    Peng, G.
    Ortuzar, W. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer
    Okamoto, Isamu
    Takeda, Koji
    Daga, Haruko
    Miyazaki, Masaki
    Yonesaka, Kimio
    Kiyota, Hidemi
    Tsurutani, Junji
    Ueda, Shinya
    Ichikawa, Yasuko
    Takeda, Masayuki
    Sekiguchi, Risa
    Tominaga, Kiyomi
    Enatsu, Sotaro
    Nambu, Yoshihiro
    Nakagawa, Kazuhiko
    [J]. LUNG CANCER, 2010, 70 (02) : 168 - 173
  • [23] PHASE II TRIAL OF PEMETREXED AND CARBOPLATIN FOLLOWED BY PEMETREXED CONTINUATION-MAINTENANCE THERAPY IN PREVIOUSLY UNTREATED ADVANCED NON-SMALL CELL LUNG CANCER
    Nishino, Kazumi
    Kijima, Takashi
    Minami, Seigo
    Komuta, Kiyoshi
    Kumagai, Toru
    Imamura, Fumio
    Yokota, Soichiro
    Takeuchi, Yoshiko
    Nakatani, Takeshi
    Uchida, Junji
    Okuyama, Takako
    Tachibana, Isao
    Kawase, Ichiro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S861 - S862
  • [24] Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non-small-cell lung cancer
    Laslett, Nicole F.
    Park, Sujung
    Masters, Gregory A.
    Biggs, David D.
    Schneider, Charles J.
    Misleh, Jamal G.
    Suppiah, Kathir
    Simpson, Pamela S.
    Grubbs, Stephen
    Wozniak, Timothy F.
    Guarino, Michael
    [J]. CANCER MEDICINE, 2018, 7 (07): : 2969 - 2973
  • [25] THE RISK OF TREATMENT WITH PEMETREXED PLUS PLATINUM FOLLOWED BY MAINTENANCE WITH PEMETREXED FOR PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER CONCURRENT WITH INTERSTITIAL LUNG DISEASE
    Fujita, Tetsuo
    Kuroki, Tsuguko
    Shiraishi, Yuka
    Amano, Hiroyuki
    Nakamura, Makoto
    Hirano, Satoshi
    Tabeta, Hiroshi
    Nakamura, Sukeyuki
    [J]. CHEST, 2019, 156 (04) : 1716A - 1716A
  • [26] RANDOMIZED PHASE II STUDY OF PEMETREXED COMPARED WITH PEMETREXED PLUS CARBOPLATIN IN PRETREATED PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (GOIRC 02/2006): PRELIMINARY RESULTS
    Tiseo, M.
    Boni, L.
    Passalacqua, R.
    Camerini, A.
    Labianca, R.
    Amadori, D.
    Boni, C.
    Ciuffreda, L.
    Di Costanzo, F.
    Ardizzoni, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 138 - 138
  • [27] Induction Pemetrexed and Cisplatin Followed by Maintenance Pemetrexed Versus Carboplatin Plus Paclitaxel Plus Bevacizumab Followed by Maintenance Bevacizumab: A Quality of Life-Oriented Randomized Phase III Study in Patients With Advanced Non-Squamous Non-Small-Cell Lung Cancer (ERACLE)
    Galetta, Domenico
    Pisconti, Salvatore
    Cinieri, Saverio
    Pappagallo, Giovanni Luigi
    Gebbia, Vittorio
    Borsellino, Nicola
    Maiello, Evaristo
    Rinaldi, Antonio
    Montrone, Michele
    Rizzo, Pietro
    Marzano, Nicola
    Sasso, Nicola
    Febbraro, Antonio
    Colucci, Giuseppe
    [J]. CLINICAL LUNG CANCER, 2011, 12 (06) : 402 - 406
  • [28] Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer
    Isamu Okamoto
    Keisuke Aoe
    Terufumi Kato
    Yukio Hosomi
    Akira Yokoyama
    Fumio Imamura
    Katsuyuki Kiura
    Tomonori Hirashima
    Makoto Nishio
    Naoyuki Nogami
    Hiroaki Okamoto
    Hideo Saka
    Nobuyuki Yamamoto
    Naoto Yoshizuka
    Risa Sekiguchi
    Kazuhiro Kiyosawa
    Kazuhiko Nakagawa
    Tomohide Tamura
    [J]. Investigational New Drugs, 2013, 31 : 1275 - 1282
  • [29] Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-na⟨ve patients with advanced nonsquamous non-small-cell lung cancer
    Okamoto, Isamu
    Aoe, Keisuke
    Kato, Terufumi
    Hosomi, Yukio
    Yokoyama, Akira
    Imamura, Fumio
    Kiura, Katsuyuki
    Hirashima, Tomonori
    Nishio, Makoto
    Nogami, Naoyuki
    Okamoto, Hiroaki
    Saka, Hideo
    Yamamoto, Nobuyuki
    Yoshizuka, Naoto
    Sekiguchi, Risa
    Kiyosawa, Kazuhiro
    Nakagawa, Kazuhiko
    Tamura, Tomohide
    [J]. INVESTIGATIONAL NEW DRUGS, 2013, 31 (05) : 1275 - 1282
  • [30] Pemetrexed plus carboplatin versus gemcitabine plus carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer
    Gronberg, B. H.
    Bremnes, R.
    Aasebo, U.
    Brunsvig, P.
    Flotten, O.
    Hjelde, H.
    Wammer, F.
    Stornes, F.
    Tollali, T.
    Sundstrom, S. H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345